Boxer Capital, LLC - 11 Aug 2023 Form 4/A - Amendment Insider Report for Tango Therapeutics, Inc. (TNGX)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
11 Oct 2023, 19:22:22 UTC
Original report date
15 Aug 2023
Prior SEC filing
24 May 2023
Next SEC filing
25 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC

Key filing fact

Boxer Capital, LLC filed Form 4/A - Amendment for Tango Therapeutics, Inc. (TNGX) on 11 Oct 2023.

Key facts

  • This page summarizes Boxer Capital, LLC's Form 4/A - Amendment filing for Tango Therapeutics, Inc. (TNGX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 11 Oct 2023, 19:22.

Change

  • Previous filing in this sequence was filed on 24 May 2023.
  • Current net transaction value: +$14,499,998.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNGX transaction

Common Stock

Award

Transaction value
$2,446,250
Shares
+475,000
Change %
+177%
Price
$5.15
Shares after
743,542
Date
11 Aug 2023
Ownership
See footnote
Footnotes
F1
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,123,642
Date
11 Aug 2023
Ownership
Direct
Footnotes
F2
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,000
Date
11 Aug 2023
Ownership
See footnote
Footnotes
F3
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,961
Date
11 Aug 2023
Ownership
See footnote
Footnotes
F4
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,988,450
Date
11 Aug 2023
Ownership
See footnote
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNGX transaction Derivative

Prefunded Warrant

Award

Transaction value
$12,053,748
Shares
+2,340,579
Change %
Price
$5.15
Shares after
2,340,579
Date
11 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,340,579
Exercise price
Footnotes
F2, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Footnote F2

These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Footnote F3

These securities are owned directly by Mr. Davis. Each reporting person other than Mr. Davis disclaims beneficial ownership of these securities.

Footnote F4

These securities are owned directly by Braslyn Ltd. Mr. Lewis is the sole indirect owner of Braslyn Ltd. Each reporting person other than Mr. Lewis disclaims beneficial ownership of these securities.

Footnote F5

These securities are owned directly by BCTG Holdings, LLC ("BCTG"). Boxer Capital is the majority member of BCTG and MVA Investors is a member of BCTG. Mr. Davis is an investment manager of BCTG. Each reporting person disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Footnote F6

The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer.

SEC remarks

This amended Form 4, which amends and restates in its entirety the original Form 4 filed on August 15, 2023, corrects the transaction codes in the original filing. These acquisitions were made in transactions with the Company under Rule 16b-3, as opposed to open market purchases. The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share, of Tango Therapeutics, Inc. (the "Issuer"). At the time of the transactions reported herein, Mr. Davis was a director of the Issuer and the other reporting persons were subject to Section 16 as directors of the Issuer on the basis of their relationships to Mr. Davis.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .